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Appropriate control of immune responses is a critical determinant of
health. Here, we show that choline acetyltransferase (ChAT) is
expressed and ACh is produced by B cells and other immune cells
that have an impact on innate immunity. ChAT expression occurs in
mucosal-associated lymph tissue, subsequent to microbial coloniza-
tion, and is reduced by antibiotic treatment. MyD88-dependent Toll-
like receptor up-regulates ChAT in a transient manner. Unlike the
previously described CD4+ T-cell population that is stimulated by
norepinephrine to release ACh, ChAT+ B cells release ACh after stim-
ulation with sulfated cholecystokinin but not norepinephrine. ACh-
producing B-cells reduce peritoneal neutrophil recruitment during
sterile endotoxemia independent of the vagus nerve, without af-
fecting innate immune cell activation. Endothelial cells treated with
ACh in vitro reduced endothelial cell adhesion molecule expression
in a muscarinic receptor-dependent manner. Despite this ability,
ChAT+ B cellswereunable to suppress effector T-cell function in vivo.
Therefore, ACh produced by lymphocytes has specific functions,
with ChAT+ B cells controlling the local recruitment of neutrophils.
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Immunity requires successfully deciphering between noxious,pathogenic insults and innocuous, self-derived antigens. Reac-
tions to self, or exaggerated immune responses, are detrimental,
resulting in autoimmunity or immunopathology. To mitigate this,
numerous regulatory mechanisms control innate and adaptive im-
munity, permitting robust responses while limiting damage. A
striking example of immunopathology resulting in mortality fol-
lowing an exaggerated immune response is septic shock and mul-
tiorgan system dysfunction. This overwhelming immune response is
typically preceded by bacteremia, although death can occur in the
absence of viable bacteria. Stimulation by pathogen-associated
molecular patterns through Toll-like receptors (TLRs) after in-
fection or exposure to bacterially derived products causes immune
effector molecule production that can have an adverse impact on
normal physiology. For example, nitric oxide produced by endo-
thelial cells and macrophages induces vasodilatation, as well as the
acute circulatory failure common in severe sepsis. In addition,
enzymes released from neutrophils recruited to the site of infection
can damage the endothelium (1, 2). This endothelial injury and the
resulting increased vascular permeability in the lung can have dev-
astating clinical consequences resulting in pulmonary edema and
acute lung injury or acute respiratory distress syndrome.Options for
therapeutic intervention are limited,with varying degrees of success,
highlighting the need for alternative approaches.
Regulation of immunity is normally accomplished by diverse
mechanisms, including glucocorticoids, anti-inflammatory cy-
tokines, soluble cytokine receptor antagonists, and the nervous
system. Until recently, modulation of immune cell function by
neurological inputs has been ignored despite the innervation of
lymphoid organs, the close physical approximation of immune
cells with neurons, and the effect of neurotransmitters on immune
cells. Examples of neural immune communication can be found
throughout the body, from the innervation of the thymus, spleen,
and Peyer’s patches (PP) (3, 4) to the neural signaling induced
by TLR ligands in the intestinal mucosa (5). The effect of this
neural input on immunity is dictated by the chemical coding of
the neurons, the receptors on the target cells, and the target cell
type. For example, ACh induces signaling through muscarinic or
nicotinic receptors, although only activation of nicotinic α7-recep-
tors on macrophages specifically reduces TNF-α production during
septic shock (6). Protection afforded by this “inflammatory reflex”
occurs following electrical (6) or cholecystokinin (CCK) (7)
stimulation of the vagus nerve. Stimulation and activation of
vagal efferents terminating in the celiac ganglion induce nor-
epinephrine (NE) release from neurons innervating the spleen,
resulting in ACh release. It is important to note that these studies
have dissected the efferent reflex arc using external stimulation
(e.g., electrical stimulation) and that the origin of the intrinsic
signals remains undetermined.
ACh is produced by the acetylation of choline, with acetyl-CoA
as the donor in the presence of choline acetyltransferase (ChAT).
As the sole enzyme that producesACh, ChATexpression indicates
cholinergic neurons that release ACh. Historically, this has led to
a paradox in the spleen. Although electrical stimulation of the
splenic ganglion induced ACh release, neuronal ChAT had not
been observed by immunohistochemistry. This splenic ACh pro-
duction was recently demonstrated to originate from CD4+ T cells
using a reporter mouse expressing GFP under the control of the
ChAT promoter (ChAT-GFP) (8). The ChAT-expressing T cells
were both necessary and sufficient to restore the inflammatory
reflex in nude mice, indicating that these cells provide the terminal
neurotransmitter in a vagus nerve-controlled circuit. These data
were in keeping with the ability of specific B- and T-cell lines to
produce ACh (9). Despite these prior studies, the factors regu-
lating ChAT expression, the site of induction, and whether other
primary immune cells are similarly capable of ACh production
were not determined.
Here, we have identified ChAT expression by B cells, dendritic
cells (DCs), and macrophages. ChAT expression begins after mi-
crobial colonization, following birth, which requires MyD88-de-
pendent signaling. These signals are derived from the intestinal
microbiota, with ChAT+ cells appearing to originate in the muco-
sal-associated lymphoid tissue (MALT). Highlighting that ChAT+
B cells are unique compared with the previously described CD4+
ChAT+ T cells, they release ACh in response to different signals.
Functionally, compared with T cells, ChAT+ B cells fulfill different
roles that limit local neutrophil recruitment independent of signals
from the vagus nerve.
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Results
ChAT-GFP Is Expressed in Specific Immune Cell Populations. Recently
documented in splenic CD4+ T cells, ChAT-GFP expression was
assessed in a variety of immune cells. As indicated in Fig. 1, ChAT-
GFP was confirmed in CD4+CD8−T cells and detected in follicular
B cells (B220+CD21+CD23+) and marginal zone (B220+CD21+
CD23int) B cells (Fig. 1A). This was not unique to the spleen, be-
causeGFP+ cells were also observed in secondary lymphoid organs,
includingmesenteric lymphnodes (MLNs), peripheral lymphnodes
(pLNs; cervical, inguinal, brachial, and axial), PP, and peripheral
blood (Fig. 1B and Fig. S1 A and B). In the thymus, no GFP ex-
pression was observed in CD4+CD8+, CD4+CD8−, or CD4−CD8+
T cells (Fig. S1C). Similarly, in the bone marrow, immature B cells
(B220int) were GFP−, with expression restricted to mature recir-
culating B cells (B220hi+IgM−IgD+) (Fig. S1D). ChAT-GFP was
also detected in peritoneal B2, B1a (B220+CD11b+CD5+), and
B1b (B220+CD11b+CD5−) cells, with B1 populations comprising
the largest percentage of ChAT-GFP+B cells (Fig. 1C). Together,
these data suggest that ChAT-GFP expression is induced in
response to specific signals received after commitment to the
CD4+ T-cell lineage in the thymus and B-cell development in
the bone marrow.
ChAT-GFP expression was also detected in splenic DCs
(FSChiCD11b−CD11c+MHCII+F4/80− and CD11b+CD11c+
MHCII+F4/80−) and macrophages (CD11b+CD11c−F4/80+) (Fig.
1 D and E). In assessing other tissues, we noted no GFP+ natural
killer (NK) cells, NK T cells, or T cells in the liver (Fig. S1E), as
well as no small intestinal intraepithelial lymphocytes (TCR-αβ
CD8-αα, TCR-γδ CD8-αα; Fig. S1F).
We validated that GFP reporter expression correlated with
ChAT expression and ACh production. As indicated in Fig. 1F,
significantly increased endogenous ChAT mRNA was detected
by quantitative RT-PCR (qRT-PCR) and ACh was detected by
MS in FACS-sorted GFP+ B cells. These data expand on the
immune cell populations that can produce ACh and suggest that
these cells reside in unique niches.
Induction of ChAT Occurs by MyD88/Antigen Receptor-Dependent
Signaling. To determine which signals were capable of inducing
ChAT expression, FACS-sorted GFP− splenic B2 cells (B220+
CD23+) and peritoneal B2, B1a, and B1b cells were stimulated
with anti-IgM/CD40L or TLR ligands. With the exception of B1a
cells, stimulation with CpG, LPS, Pam3Cys, R848, or anti-IgM +
CD40L but not the MyD88-independent stimuli polyinosinic:
polycytidylic acid (Fig. 2A) induced ChAT-GFP expression.
To test the role of MyD88 in ChAT induction directly, sorted
splenic GFP− B2 cells from ChAT-GFP+ MyD88−/− or MyD88+/+
mice were stimulated with TLR ligands. As indicated in Fig.
2B, ChAT-GFP induction was significantly reduced in MyD88−/−
compared with MyD88+/+ mice. The ability of these TLR ligands
to induce ChAT expression in a cell-intrinsic manner was tested
using FACS-sorted splenic B220+CD23+GFP− cells from ChAT-
GFP+ MyD88−/− and MyD88+/+ mice. Cells were differentially
labeled with the tracking dyes cell trace violet (MyD88−/−) and
efluor670 (MyD88+/+), mixed in a 1:1 ratio, and stimulated with
TLR ligands. As before, TLR stimulation induced GFP ex-
pression in MyD88+/+ but not MyD88−/− cells, either stimulated
alone or cocultured with WT cells (Fig. S2). MyD88 signaling
was also required for in vivo induction of ChAT, with significant
reductions in GFP+ B cells and CD4+ T cells observed in the
bonemarrow, spleen, peritoneum, PP, andMLN of theMyD88−/−
mice (Fig. 2 C and D). Together, these results demonstrate that
specific signaling events through the antigen receptor or trans-
duced through MyD88 are required for the induction of ChAT
expression in immune cells.
Production of ChAT-GFP+ Cells Occurs After Birth and Depends on
Microbial Colonization. Because TLR ligands induced ChAT-GFP
expression in immune cells, we considered that postnatal microbial
colonization might induce lymphocyte ChAT expression in vivo.
Consistent with this hypothesis, B220+GFP+ splenocytes were
absent in embryonic day (E) 18.5 fetuses confirmed to be ChAT-
GFP+ by genotyping (Fig. S3A). Fetal B cells became activated by
LPS or R848 as indicated by increased CD69 expression, and in-
duced ChAT-GFP in a comparable manner to adult B cells (Fig.
S3B). Analysis of neonatal mice on postnatal day 7 revealed the
presence of B220+GFP+ B cells; however, this population was
significantly smaller compared with adult mice (Fig. S3C). These
data demonstrated that B cells in utero have not received the
appropriate stimuli to induce ChAT expression and that this
occurs after birth.
To test the role of the microbiota in the induction of ChAT
directly, mice were treated at weaning with an antibiotic mixture in
the drinking water for 4 wk (10). Antibiotic treatment significantly
reduced the colonic microbiota (Fig. 3A) and the frequency of
ChAT-GFP+ cells. With respect to B220+CD23+ B cells, this re-
duction occurred in the PP, MLN, and spleen, as well as in peri-
toneal B1a, B1b, and B2 B cells (Fig. 3 B and C). Depletion of the
microbiota also reduced CD4+ChAT-GFP+ cells in the PP but not
in the MLN or spleen (Fig. 3D).
To assess which of these tissues contributed to ChAT induction
in vivo, mice were treated with the synthetic sphingosine 1 phos-
phate analog FTY720 (1 mg·kg·d, administered for 7 d). Treatment
with this compound has been demonstrated to prevent lymphocyte
egress from secondary lymphoid organs (11). Highlighting the im-
portance of the mucosal immune system in generating ChAT+ T
cells andB cells, significantly increased numbers of CD4+GFP+ and
B220+GFP+ cells were observed in the MLN, with corresponding
decreases in the pLN and spleen (Fig. 3 E and F). These data
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Fig. 1. ChAT-GFP is expressed in multiple immune cells. (A) Flow cytometry
for GFP expression was conducted on splenocytes for CD4+ and CD8+ T cells
(Left) and marginal zone (MZ) and follicular B (FOB) cells (Right). ChAT+ cells
were also enumerated in the PP and MLN (B) and in peritoneal B1a, B1b, and
B2 B cells (C). Splenic DCs (D) and macrophages (E) were assessed for ChAT-
GFP. (F) ChAT and ACh production was assessed by qRT-PCR (Left) and by MS
from splenic B220+CD23+ B cells (Right) (n = 3 mice repeated three times).
#P <0.001 by ANOVA.
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indicate that signals to induce ChAT are received in MALT as
opposed to other peripheral sites, such as the spleen.
ChAT-GFP+ Expression Is Transient, and ACh Is Produced on Demand.
To determine if ChAT expression was stable in lymphocytes,
a genetic fate-map approach was used. Mice expressing Cre
recombinase under the endogenous ChAT promoter and dsTo-
matoLSL were bred to ChAT-GFP mice. Cells from these progeny
currently expressing ChAT are GFP+Tomato+, whereas previous
expression is indicated by GFP−Tomato+. Under steady-state
conditions, Tomato+ B cells and T cells were GFP− and GFP+
(Fig. 4 A–C), indicating that ChAT expression can be induced and
terminated in vivo. Highlighting this transient nature, LPS stimu-
lation of sorted GFP−Tomato+ B cells resulted in GFP reex-
pression (Fig. 4D). Together, these data demonstrate that ChAT
expression in lymphocytes is transient and can be reinduced by the
appropriate stimuli.
In considering if ACh was stored or produced on demand by
ChAT+ cells, FACS-sorted GFP− and GFP+ splenic B2 B cells
were stimulated with LPS ± 4-(1-naphthyl)vinyl pyridine (NVP),
a selective and irreversible inhibitor of ChAT. Short-term (0.5 h)
treatment with LPS or NVP failed to alter the amount of ACh
detected in cell lysates by MS (Fig. 4E). Long-term (overnight)
exposure to LPS significantly enhancedACh production from cells
originally GFP− and GFP+ but was prevented by cotreatment with
NVP. These data indicate that ACh detected in freshly isolated
cells ex vivo is preformed, with inhibition of ChAT affecting de
novo synthesis.
Specific Receptors Expressed by ChAT-GFP+ Immune Cells Facilitate
ACh Release. In the nervous system, ACh is preformed in vesicles
and released following coordinated input of specific neurotrans-
mitter signals. Using an 84-gene qRT-PCR array on mRNA from
FACS-purified splenic ChAT-GFP+ or GFP− B2 cells, we iden-
tified ∼20 genes, including several neurotransmitters and hormone
receptors, that are differentially expressed in GFP+ and GFP− cells
(Tables S1 and S2). Validating this array approach, endogenous
ChAT and ACh esterase (AChE) were expressed in B220+GFP+
cells but not in B220+GFP− cells. Demonstrating the expression and
functionality of these receptors, stimulation of GFP+ but not GFP−
B cells with CCKs caused ACh release as assessed by MS (Fig. 5A).
Critically, these B cells respond to unique stimuli compared with
ChAT-expressing CD4+ cells, because NE failed to induce ACh
release (Fig. 5B). Together, these data demonstrate that B cells
possess selective receptors for hormones and neurotransmitters, and
that stimulation through specific receptors will drive ACh release.
ChAT+ Lymphocytes Do Not Restrain Effector CD4 T-Cell Function.
The previously described ChAT+ CD4+ T cells were found
to possess a phenotype characteristic of regulatory cells (e.g.,
CD45RBlo) (8). Here, we sought to determine if these GFP+
B-cell and T-cell populations would suppress effector T cells in
the adoptive transfer model of colitis (12). Colonic inflammation
occurs following the transfer of FACS-sorted effector CD4+
CD45RBhi T cells into Rag1−/− mice. Six to eight weeks after
transfer, mice begin to display characteristic hallmarks of disease,
including weight loss, diarrhea, and extensive T-cell infiltration, as
evidenced by histological examination following necropsy. Disease
pathogenesis can be prevented by cotransfer of FACS-sorted
CD45RBlo regulatory cells.
As expected, transfer of CD4+CD45RBhi T cells induced
intestinal inflammation that was suppressed by cotransfer of
CD45RBlo regulatory cells. Cotransfer of CD4+ ChAT-GFP+
cells but not CD4+ ChAT-GFP− cells also reduced hallmarks of
disease, including weight loss (Fig. S4A), reduced colon length
(Fig. S4B), macroscopic disease (Fig. S4C), histological damage
(Fig. S4D), and IFN-γ–producing CD4+ effector T cells in the
MLN (Fig. S4E).
Although these data suggested that ChAT+ T cells could sup-
press effector function, subsequent analysis indicated that this
population was composed of known regulatory cell types. In-
tracellular staining following FACS sorting revealed enrichment
for Foxp3+Helios− and Foxp3+Helios+ in CD4+ ChAT-GFP+ T
cells (Fig. S4F), although in vitro regulatory T-cell (Treg) differ-
entiation failed to induce ChAT-GFP expression (Fig. S4G). Using
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Fig. 2. MyD88-dependent signaling regulates ChAT expression in immune
cells. (A) Sorted GFP− peritoneal (PEC) B1a, B1b, or B2 cells or splenic (SPL) B2
cells were stimulated (16 h) with anti-IgM/CD40 (10 μg/mL and 5 μg/mL, re-
spectively), polyinosinic:polycytidylic acid [Poly(I:C); 100 μg/mL], CpG (10 μM),
LPS (10 μg/mL), Pam3cys (1 μM), or R848 (1 μg/mL) and assessed for GFP. (B)
FACS-sorted GFP− splenic B2 cells from MyD88+/+ Chat-GFP−, MyD88+/+
ChAT-GFP+, and MyD88−/− ChAT-GFP+ mice were stimulated with TLR
ligands. ChAT expression in MyD88−/− mice was assessed by flow cytometry
on SPL follicular B cells (C, Left) and CD4+ T cells (C, Right), summarized from
PEC, SPL, MLN (mLN), pLN, and PP cells (D) (n = 3 mice repeated three times).
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Fig. 3. Intestinal microbiota contribute to ChAT+ lymphocyte development.
(A) Antibiotics (Abx) were administered in the drinking water to deplete the
microbiota. (B) Follicular B cells were assessed in control (white bars) and
antibiotic-treated (black bars) mice in the PP, MLN, and spleen. (C) Effect of
microbiota depletion was also assessed in peritoneal B1a, B1b, and B2 B cells.
(D) Analysis of the CD4+ T-cell population was also conducted in the PP, MLN,
and spleen. In separate experiments, mice were gavaged with vehicle (con-
trol, open bars) or FTY720 (solid bars). GFP expression was assessed on cells
from the PP, MLN, pLN, and spleen in CD4+ T cells (E ) and B220+ B cells (F )
(n = 3 to 4 mice per group, two experiments). Abs. No., absolute number.
*P < 0.05 and #P < 0.001 by ANOVA.
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a cytokine secretion assay, we found that few ChAT-GFP+ cells
produced IL-10 after in vitro stimulation (Fig. S4H). Thus, a sig-
nificant proportion of CD4+ChAT-GFP+T cells are nTregs/iTregs
but not type 1 regulatory (TR1) cells. As a whole, these data sug-
gest that reduced colitis burden was not due toACh production but
was the result of transfer of ChAT+ cells that were classic Tregs. In
support of this, suppression by CD4+ ChAT-GFP+ cells was not
observed in recipients of CD4+CD45RBhi cells from mice with
a dominant negative TGF-β1 receptor (CD4-dnTGFβRII; Fig.
S5A).
With respect to the B cells, although a fraction of B220+CD23+
ChAT-GFP+B cells produced IL-10, cotransfer with effector CD4
T cells failed to prevent colitis (Figs. S4I and S5B). Thus, these cells
are discrete from the previously described regulatory B-cell pop-
ulation and do not act as suppressors of adaptive immune function.
ChAT+ B Cells Regulate Innate Immunity. With the previous identi-
fication of CD4+ ChAT+ T cells being required for the inflam-
matory reflex arc, we assessed if ChAT+ B cells influence innate
immunity. To this end, FACS-sortedGFP+ orGFP−B1 or B2 cells
were transferred into Rag1−/− mice, with neutrophil recruitment
and cytokine production assessed after LPS injection (0.2 mg/kg).
Neutrophil (SSChiCD11b+GR1hi) recruitment into the perito-
neum 3 h after LPS injection was significantly reduced in recipients
of GFP+ but not GFP− B1 or B2 cells (Fig. 6A). Highlighting the
difference between ChAT+ B cells and the previously described
CD4+ ChAT+ T-cell population, we noted no reduction in TNF-α
or other cytokines and chemokines [monocyte chemotactic pro-
tein-1 (MCP-1), IL-6, or IL-10] over the duration of the experi-
ment (Fig. 6B). These data indicated that ACh-producing B cells
limit neutrophil influx during sterile sepsis by a mechanism in-
dependent of innate immune activation.
To ascertain if the reduced neutrophil recruitment required an
intact vagal nerve, a subdiaphragmatic vagotomy (VGX) or sham
operation was performed on Rag1−/− mice. After 2 wk, sorted
GFP− orGFP+B1 cells were adoptively transferred and challenged
with LPS as before. Reduced polymorphonuclear cell recruitment
was observed in Rag1−/− recipients of GFP+ B1 cells that had
a VGX performed, excluding a role of the vagus nerve (Fig. 6C). In
these experiments, we further sought to determine if reduced
neutrophil recruitment was due to decreased production of typical
chemokines. Analysis of the serum from these mice revealed no
reduction in an expanded panel of chemokines, including eotaxin,
MCP-1, macrophage inflammatory protein (MIP)-1α, MIP-β,
keratinocyte-derived chemokine (KC), and regulated on activa-
tion, normal T-cell expressed and secreted (RANTES) or cytokines
(Fig. 6D).
Attenuated recruitment without reduced innate immune activa-
tion suggested decreased interactions and transmigration across the
endothelium. Previously, decreased expression of intracellular ad-
hesion molecule-1 (ICAM-1), vascular cell adhesion molecule
(VCAM), and E-selectin has been observed following treatment
with ACh and mimetics of ACh (13). Here, we assessed if ACh
treatment ofmouse endothelial cells would prevent TNF-α–induced
increases in cell surface ICAM-1 andVCAM.As indicated in Fig. 7,
ACh pretreatment reduced basal and induced adhesion molecule
expression in a dose-dependent manner. Mechanistically, ACh-in-
duced signaling through muscarinic receptors was required, with
atropine pretreatment restoring TNF-α–induced ICAM and
VCAM expression (Fig. 7 A and B). Excluding a role for nicotinic
α7-receptors, the selective agonist PHA543613 failed to inhibit
adhesion molecule expression induced by TNF-α (Fig. S6).
These data demonstrate that localized ACh release by peri-
toneal B cells can reduce neutrophil recruitment without re-
ducing the production of proinflammatory factors. These cells
influence recruitment through inhibition of adhesion molecule
expression on endothelial cells.
Discussion
Communication between the nervous and immune systems occurs
throughout the body and modulates numerous physiological pro-
cesses. Examples of this neural–immune interaction are abundant,
with neurotransmitters having an impact on adaptive and innate
immunity, such as inhibition of TNF-α production by ACh (14).
Activation of this inflammatory reflex arc significantly reduces
mortality in models of septic shock through the ligation of nicotinic
α7-receptor (6).
Immune cells can also function as integral components in neu-
ronal circuits as opposed to target cells. Reduced mortality during
sepsis by the inflammatory reflex arc was shown to be dependent
on ACh producing T cells (8). These CD4+ ChAT+ T cells were
intermediaries relaying neuronal signals to macrophages, reducing
TNF-α production during sepsis. Whether other immune cells
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Fig. 5. Specific stimuli induce release of ACh. Release of AChwas determined
from FACS-sorted B220+CD23+ ChAT-GFP− or ChAT-GFP+ splenic B cells, fol-
lowing stimulation with CCK (A) or NE (B) with 10 μMphysostigmine bromide
(20 min). Supernatants were mixed 1:1 with methanol (MeOH) and assessed
by MS. As a control, sorted ChAT-GFP+ and ChAT-GFP− cells were lysed with
MeOH and mixed 1:1 with a PBS “pellet” (n = 3, measured in duplicate). *P <
0.05 by ANOVA.
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expressed this enzyme and the origin, development, and other
immunological functions were not known.
The data presented in this study demonstrated that ChAT is
expressed by B cells, macrophages, andDCs. This expression occurs
in response to TLR agonists that elicit MyD88-dependent signal
transduction in a cell-intrinsic manner. In accordance with these
data, ablation of MyD88 significantly reduces ChAT expression
following in vitro stimulation and reduces ChAT+ lymphocytes in
vivo. This impact ofMyD88 deficiency on ChAT expression appears
to be unique to immune cells. Although a deficiency in MyD88
increases neural progenitor cell proliferation, ChAT expression is
unaltered (15). This is in keeping with neuronal ChAT being in-
duced at the transcription level by neurotrophins (16). Further
highlighting the uniqueness of ChAT in immune cells, signals that
induce expression occur after birth and originate from the host
microbiota. Corroborating this, expression in lymphocytes is absent
in utero (E18.5) but develops by postnatal day 7, a time when the
microbiota is being established (17). Supporting this role, depletion
of the microbiota by antibiotic treatment subsequently reduced
ChAT expression in B cells and T cells. Although sites other than
the colon represent unique niches for different commensal micro-
organisms, it appears that cells acquire the ability to produceACh in
intestinal MALT. Increased retention of ChAT+ lymphocytes was
observed in MALT but not in other peripheral secondary lymphoid
organs (e.g., spleen) following FTY720 treatment. These data
would suggest that signals in the MALT induce ChAT expression,
followed by emigration of these cells to other peripheral sites.
Our data show that the capability of immune cells to produce
ACh is transient rather than being a defined lineage. Using a fate-
map approach, cells that had previously expressed this enzymewere
capable of reexpression, suggesting dynamic regulation as opposed
to an enforced lineage. In a fashion similar to neurons, ACh is
preformed by immune cells and is released following appropriate
stimulation. These signals that induce ACh release are divergent
from the previously described ChAT+ T-cell population. Although
stimulation through β2-adrenergic receptors by NE induced ACh
release by CD4+ ChAT+ T cells (8), NE was without effect on B
cells. Several receptors for neurotransmitters and hormones were
expressed by ChAT+ B cells, suggesting that specific inputs control
the B-cell ACh pathway. It is tempting to speculate that additional
neural inputs could modulate ACh release and fine-tune the
response.
With complex regulation of ACh release from immune cells, it
seemed plausible that ChAT-expressing lymphocytes could exert
control over numerous immunophysiological processes. Having
previously established the CD4+ ChAT+ cells in sepsis, the ability
of these cells to modulate adaptive immunity was investigated.
Using the T-cell adoptive transfer model of colitis, suppression of
disease was observed with cotransfer of CD4+ ChAT-GFP+ T
cells. Suppression of effector T-cell function, and prevention of
colitis, appears to be due to the high degree of natural and in-
ducible Tregs that comprise the ChAT-GFP+T-cell population. In
keeping with this, cotransfer of ChAT-GFP+ and effector T cells
from mice with CD4 cells expressing CD4-dnTGFβRII resulted in
disease. Therefore, suppression is likely due to TGF-β1 and not to
ACh produced by the CD4+ ChAT+ population. Similarly, co-
transfer of ChAT+ B cells failed to provide protection in the
adoptive transfer model of colitis. These data indicate that ChAT
expression is a property of known Treg populations, althoughACh
does not prevent effector T-cell function.
Modulation of innate immune responses by ACh is site-specific
and dependent on the immune cells targeted. As evidence of this,
although the release of ACh from T cells following stimulation of
the vagal nerve reduces proinflammatory cytokines, this was not
observed with B cells. Here, we identified that ChAT+ B cells do
not have an impact on proinflammatory cytokine or chemokine
production during sterile endotoxemia but reduce local neutrophil
recruitment. Reduced recruitment should not be equated to re-
duced host defense, because ACh has been shown to increase
bactericidal activity by neutrophils or macrophages in a muscarinic
or nicotinic α4β2-receptor–dependent but not α7-receptor–de-
pendent manner (18).
Systemic reduction of neutrophil recruitment following vagal
nerve stimulation (VNS) has been described previously (19). This
systemic effect is fundamentally different from the reduced lo-
calized recruitment into the peritoneum in recipients of ChAT-
GFP+ B cells. In contrast to VNS, control afforded by B cells did
not require an intact vagus nerve, because reduced recruitment
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Fig. 6. B cell-derived ACh is required for neutrophil recruitment. Peritoneal
B1 or splenic B2 cells were enriched and FACS-sorted based on ChAT-GFP
expression. Cells were transferred (2 × 105, i.p.) to Rag1−/− recipients, and LPS
(0.2 mg/kg) was injected 16 h after transfer. (A) Neutrophils were assessed
3 h after challenge with LPS. Abs. No., absolute number. (B) Serum was
assessed for cytokine production by cytometric bead assay. (C) Rag1−/− sham
or vagotomized (VGX) mice received FACS-sorted GFP− or GFP+ peritoneal B1
cells. Mice were challenged with LPS (0.2 mg/kg) and assessed for peritoneal
neutrophil recruitment (C) and serum chemokines (D) (n = 3–7 mice per group
in two separate experiments). *P < 0.05, two-tailed t test (A) and two-way
ANOVA (C).
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was observed in mice that underwent a VGX. Although direct
effects on neutrophils following systemic administration of selec-
tive nicotinic α7-agonists have been suggested previously (20), it is
unlikely that endogenous ACh could act in this fashion. This effect
on circulating cells is inconsistent with reduced localized re-
cruitment, as well as with the short t1/2 of ACh in serum due to the
presence of AChE.
Decreased peritoneal recruitment without impinging on cyto-
kine or chemokine production suggested that endothelial adhesion
molecule expression was reduced. Stimulation of mouse endo-
thelial cells with TNF-α increased ICAM andVCAM-1 expression
that was inhibited by pretreatment with ACh but not a highly se-
lective α7-agonist. In agreement with our data, reduced TNF-
α–induced expression of ICAM-1, E-selectin, and P-selectin has
been observed with treatment of humanmicrovascular endothelial
cells (13) with ACh or mimetics. Suggesting a difference between
mouse and human endothelial cells, these studies demonstrated
reduced adhesion molecule expression with a nicotinic α7-agonist.
Nicotine alone has, however, been reported to increase E-selectin,
ICAM, and VCAM on human umbilical vein endothelial cells in
vitro (21). Whether these differences are due to activation of non–
α7-receptors or represent differences in endothelial cells isolated
from different sources is uncertain. At this point, it is uncertain
what muscarinic receptors are required for the observed reduction
in ICAM-1 expression. Signaling through a G protein-coupled
receptor that increases cAMP and c-Fos phosphorylation has been
shown to block NF-κB–dependent gene expression (22). Whether
this mechanism is responsible for our observations is not known
and will require subsequent study.
This ability of ChAT+ B cells to control neutrophil recruitment
and activity rapidly is in keeping with the protective effects of CD4+
T cells during sepsis. Although the recruited cells are bactericidal,
release of effector molecules and enzymes, such as neutrophil
elastase, causes significant tissue damage, contributing to pathol-
ogy. Endothelial cell injury and the resulting increased vascular
permeability in the lung can have devastating clinical consequences.
Pulmonary edema, due to the leakage of protein-richfluid across the
microvascular endothelium, compromises lung function, resulting in
oxygen therapy refractive cyanosis. Although a number of clinical
presentations can precipitate the development of acute respiratory
distress syndrome, sepsis is by far the most prevalent cause (2).
Severe pathology from overabundant neutrophil activation or dys-
regulation of neutrophil proteolytic enzymes has also been observed
in a model of intestinal inflammation (12). Therefore, immunopa-
thology in a diverse number of tissues may be limited by ChAT+ B
cells through reducing endothelial adhesion molecule expression,
limiting damage due to neutrophil influx and effector release.
Materials and Methods
Detailed information on materials and methods used in this study is provided
in SI Materials and Methods.
Mice. All mice, including those that underwent a VGX (or sham operation)
were purchased from Jackson Laboratories. Mice were treated with FTY720
by oral gavage (1 mg·kg·d). Microbiota depletion was accomplished using
a mixture of oral antibiotics. Endotoxemia was induced by i.p. injection of
LPS (0.2 mg/kg). T cell-induced colitis was performed by transfer of FACS-
sorted cells as published previously (12).
Chemicals. ACh, NE, physostigmine bromide, and LPS were from Sigma–
Aldrich, and PHA543613 and CCKs were purchased from Tocris Bioscience.
Cells. The mouse endothelial cell line Bend.3 was purchased from the
American Type Culture Collection.
Flow Cytometry. Isolated immune cells were assessed according to standard
protocols.
qRT-PCR and qRT-PCRarray. cDNAwas prepared from sorted immune cells, and
qRT-PCR was conducted using primers from the PrimerBank (23) or PCRarray
(SABiosciences).
MS. FACS-sorted immune cells were lysed or stimulated to release ACh.
Samples were spiked with deuterated-ACh internal standard (Sigma–Aldrich)
and analyzed by LC-tandem MS.
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